On August 29, 2024 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, reported that Chief Executive Officer Masoud Toloue and Chief Financial Officer Vandana Sriram will take part in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 6, 2024 at 1:50 p.m. ET (Press release, Quanterix, AUG 29, 2024, View Source [SID1234646223]). The presentation will be available virtually and participants can register here. The presentation will be available for viewing following the conference on Quanterix’s website here: ir.quanterix.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To learn more about Quanterix, visit www.quanterix.com/company/. To learn more about Quanterix’s Simoa technology, visit: www.quanterix.com/simoa-technology/.